Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Humana Inc. (HUM)

Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of Humana Inc. (NYSE: HUM) against certain of their officers and directors for alleged breaches of fiduciary duty. Shareholders who have held shares continuously since prior to the dates listed below may have standing to seek corporate governance reforms focused on executive oversight, the return of funds to the Company, and a court-approved incentive award, at no cost to them.

If you have held Humana shares continuously since prior to July 27, 2022, you may have standing to seek corporate governance reforms focused on executive oversight at Humana.

To learn more, contact Johnson Fistel, PLLP at jimb@johnsonfistel.com or (619) 814-4471.

Complaint Allegations
A previously filed securities class action complaint alleges that throughout the class period Defendants made false and/or misleading statements and failed to disclose material adverse facts regarding Humana’s business and financial performance. Specifically, the complaint alleges that Defendants downplayed pressures on Humana’s adjusted earnings per share caused by rising medical costs associated with increased healthcare utilization following the easing of COVID-related disruptions. According to the complaint, these cost trends were not adequately reflected in Humana’s guidance, rendering Defendants’ public statements materially false or misleading when made.